{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:14:09Z","timestamp":1793985249742,"version":"4.8.0"},"reference-count":53,"publisher":"Wiley","issue":"8b","license":[{"start":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T00:00:00Z","timestamp":1215561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2009,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Extracts from <jats:italic>Pygeum africanum<\/jats:italic> are used in the treatment of prostatitis, benign prostatic hyperplasia and prostate cancer (Pca), major health problems of men in Western countries. The ligand\u2010activated human androgen receptor (AR) supports the growth of the prostate gland. Inhibition of human AR by androgen ablation therapy and by applying synthetic anti\u2010androgens is therefore the primary goal in treatment of patients. Here, we show that atraric acid (AA) isolated from bark material of <jats:italic>Pygeum africanum<\/jats:italic> has anti\u2010androgenic activity, inhibiting the transactivation mediated by the ligand\u2010activated human AR. This androgen antagonistic activity is receptor specific and does not inhibit the closely related glucocorticoid or progesterone receptors. Mechanistically, AA inhibits nuclear transport of AR. Importantly, AA is able to efficiently repress the growth of both the androgen\u2010dependent LNCaP and also the androgen\u2010independent C4\u20132 Pca cells but not that of PC3 or CV1 cells lacking AR. In line with this, AA inhibits the expression of the endogenous prostate specific antigen gene in both LNCaP und C4\u20132 cells. Analyses of cell invasion revealed that AA inhibits the invasiveness of LNCaP cells through extracellular matrix. Thus, this study provides a molecular insight for AA as a natural anti\u2010androgenic compound and may serve as a basis for AA derivatives as a new chemical lead structure for novel therapeutic compounds as AR antagonists, that can be used for prophylaxis or treatment of prostatic diseases.<\/jats:p>","DOI":"10.1111\/j.1582-4934.2008.00426.x","type":"journal-article","created":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T09:49:50Z","timestamp":1215510590000},"page":"2210-2223","source":"Crossref","is-referenced-by-count":50,"title":["The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth"],"prefix":"10.1111","volume":"13","author":[{"given":"Maria","family":"Papaioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Schleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Prade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Degen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Roell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Undine","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamzin","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Claessens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Matusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Baniahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,9]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2077"},{"key":"e_1_2_5_3_2","first-page":"109","article-title":"Lower urinary tract symptoms and benign prostatic hyperplasia","volume":"56","author":"Skolarikos A","year":"2004","journal-title":"Minerva Urol Nefrol."},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00350-1"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000139539.94828.29"},{"key":"e_1_2_5_6_2","first-page":"45","article-title":"Serum testosterone levels in healthy young black and white men","volume":"76","author":"Ross R","year":"1986","journal-title":"J Natl Cancer Inst."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490469"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01593-5"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(97)00087-3"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.99-0943rev"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R100041200"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/35094009"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(99)00049-7"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1677\/erc.0.0090155"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0765"},{"key":"e_1_2_5_16_2","first-page":"2511","article-title":"Selection for androgen receptor mutations in prostate cancers treated with and\u2010 rogen antagonist","volume":"59","author":"Taplin ME","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.6.5.4375"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/76287"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.20794"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690684"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00123a026"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002409900098"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-002-0247-6"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02155-6"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-007-0014-y"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-946638"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(97)00176-3"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend.16.4.0798"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203268200"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.22.10633"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.8.4.440"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.1.232"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2003.10.036"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.283"},{"key":"e_1_2_5_35_2","first-page":"2577","article-title":"Androgen\u2010independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer","volume":"54","author":"Thalmann GN","year":"1994","journal-title":"Cancer Res."},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(02)00411-2"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.2006-0468"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(94)90119-8"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.10.2.471"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/307747a0"},{"key":"e_1_2_5_41_2","first-page":"22","article-title":"Intranuclear localization of hormone\u2010occupied and \u2010unoccupied estrogen receptors in the mouse uterus: application of 1 nm immunogold\u2010silver enhancement procedure to ultrathin frozen sections","volume":"44","author":"Yamashita S","year":"1995","journal-title":"J Electron Microsc."},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0604193103"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M602237200"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206374200"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00471-9"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.12.032"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm972"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.1990.tb00189.x"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.3109\/00498259609046693"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0223-5234(02)01335-1"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00026.2006"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2007.10.013"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2930761"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203310200"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1582-4934.2008.00426.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1582-4934.2008.00426.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1582-4934.2008.00426.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1582-4934.2008.00426.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:07:19Z","timestamp":1692724039000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1582-4934.2008.00426.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,9]]},"references-count":53,"journal-issue":{"issue":"8b","published-print":{"date-parts":[[2009,8,2]]}},"alternative-id":["10.1111\/j.1582-4934.2008.00426.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00426.x","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,9]]}}}